Spravato Esketamine Nasal Spray Device Instruction Manual
- June 6, 2024
- Spravato
Table of Contents
Spravato Esketamine Nasal Spray Device
Nasal Spray Device
Each device delivers two sprays containing a total of 28 mg of esketamine.
Step 1 Get ready
Before first device only:
Instruct patient to blow nose before first device only.
Confirm required number of devices.
56 mg = 2 devices
84 mg = 3 devices
Step 2 Prepare device
Healthcare professional:
-
Check expiration date (`EXP’). If expired, get a new device.
-
Peel blister and remove device.
Healthcare professional: -
Do not prime device. This will result in a loss of medication.
-
Check that indicator shows 2 green dots. If not, dispose of device and get a new one
-
Hand device to patient. cp-81317v2
Step 3 Prepare patient
Instruct the patient to:
- Hold device as shown with the thumb gently supporting the plunger.
- Do not press the plunger.
Instruct the patient to:
- Recline head at about
45 degrees during administration to keep medication inside the nose.
Step 4 Patient sprays once into each nostril
Instruct the patient to:
-
Insert tip straight into the first nostril.
-
Nose rest should touch the skin between the nostrils.
Instruct the patient to:
-
Close opposite nostril.
-
Breathe in through nose whilepushing plunger all the way up until it stops.
Instruct the patient to: -
Sniff gently after spraying to keep medication inside nose.
Instruct the patient to: -
Switch hands to insert tip into the second nostril.
-
Repeat Step 4 to deliver second spray.
Step 5 Confirm delivery and rest
Healthcare professional:
-
Take device from patient.
-
Check that indicator shows no green dots. If you see a green dot, have patient spray again into the second nostril.
-
Check indicator again to confirm device is empty.
Instruct the patient to: -
Rest in a comfortable position (preferably, semi -reclined) for 5 minutes
after each device. -
If liquid drips out, dab nose with a tissue.
Do not blow nose.
Next device
Healthcare professional:
- Repeat Steps 2-5 for the next device.
IMPORTANT: Ensure that patient waits 5 minutes after each device to allow medication to absorb.
Disposal
Dispose of used device(s) per facility procedure for a Schedule III drug
product and per applicable federal, state, and local regulations.
This Instructions for Use has been approved by the U.S. Food and Drug
Administration.
Manufactured for:
Janssen Pharmaceuticals, Inc. Titusville, NJ 08560
Revised: November 2019
© 2019 Janssen Pharmaceutical Companies
Documents / Resources
|
Spravato Esketamine Nasal Spray
Device
[pdf] Instruction Manual
Esketamine, Nasal Spray Device
---|---
Read User Manual Online (PDF format)
Read User Manual Online (PDF format) >>